ORBIS INVESTMENT MANAGEMENT LTD - 31 Dec 2025 SCHEDULE 13G/A Report for CRISPR Therapeutics AG Common Stock (CRSP)

Filing Manager: ORBIS INVESTMENT MANAGEMENT LTD
Reporting Manager: ORBIS INVESTMENT MANAGEMENT LTD
Security: CRISPR Therapeutics AG Common Stock
Symbol: CRSP
Shares outstanding: 95,714,968 shares
Disclosed Ownership: 5,934,328 shares
Ownership: 6.2%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 12:06:20 UTC
Date of event: 31 Dec 2025
Previous filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIS INVESTMENT MANAGEMENT LTD	6.2%	5,934,328	5,934,328	0	Matthew Gaarder	Attorney-in-Fact
Allan Gray Australia Pty Ltd	0%	15,817	15,817	0	Matthew Gaarder	Attorney-in-Fact